Back
Aurinia Pharmaceuticals Vs. Edesa Biotech Industry Stock Comparison
Sell
40
AUPH
Aurinia Pharmaceuticals
Last Price:
5.75
Seasonality Move:
0.65%
Sell
31
EDSA
Edesa Biotech
Last Price:
4.47
Seasonality Move:
4.84%
Sell
40
Aurinia Pharmaceuticals (AUPH)
is a Sell
Is Aurinia Pharmaceuticals a Buy, Sell or Hold?
- The current Aurinia Pharmaceuticals [AUPH] share price is $5.31. The Score for AUPH is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- AUPH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
31
Edesa Biotech (EDSA)
is a Sell
Is Edesa Biotech a Buy, Sell or Hold?
- The current Edesa Biotech [EDSA] share price is $4.51. The Score for EDSA is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- EDSA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AUPH Stock Price Chart
What is Aurinia Pharmaceuticals's stock price today?
-
The Aurinia Pharmaceuticals share price today is $5.31
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AUPH is experiencing slight selling pressure.
EDSA Stock Price Chart
What is Edesa Biotech's stock price today?
-
The Edesa Biotech share price today is $4.51
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDSA is experiencing selling pressure, which indicates risk of future bearish movement.
AUPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 57.75 | Buy |
| Chaikin Money Flow: | -113970 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.95 - 5.17) | Buy |
| Bollinger Bands (100): | (4.86 - 7.88) | Sell |
EDSA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 51 | Buy |
| Chaikin Money Flow: | -21462 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.36 - 4.56) | Buy |
| Bollinger Bands (100): | (4.29 - 4.91) | Sell |
AUPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.14 | Buy |
| 20-day SMA: | 5.07 | Buy |
| 50-day SMA: | 5.11 | Buy |
| 200-day SMA: | 7.48 | Sell |
| 8-day EMA: | 5.15 | Buy |
| 20-day EMA: | 5.12 | Buy |
| 50-day EMA: | 5.38 | Sell |
| 200-day EMA: | 7.1 | Sell |
EDSA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.53 | Sell |
| 20-day SMA: | 4.48 | Buy |
| 50-day SMA: | 4.42 | Buy |
| 200-day SMA: | 4.64 | Sell |
| 8-day EMA: | 4.52 | Sell |
| 20-day EMA: | 4.5 | Buy |
| 50-day EMA: | 4.5 | Buy |
| 200-day EMA: | 5.11 | Sell |
Aurinia Pharmaceuticals Earnings Growth & AUPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.65 per share, and an increase next year of $0.35 per share.
Edesa Biotech Earnings Growth & EDSA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aurinia Pharmaceuticals Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Edesa Biotech Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||